Product details
Catalog number BNC882299-500
Price for BNC882299-500
Size / count 1x 500 µL
This MAb is specific to ER alpha and shows minimal cross-reaction with other members of the family. ER is an important regulator of growth and differentiation in the mammary gland. Presence of ER in breast tumors indicates an increased likelihood of response to anti-estrogen (e.g. tamoxifen) therapy. This MAb is excellent for staining of formalin-fixed, paraffin-embedded breast carcinomas.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/2299R), CF488A conjugate, 0.1mg/mL is BNC882299-500.
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/2299R), CF488A conjugate, 0.1mg/mL is available in the following size(s): 1x 500 µL.
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/2299R), CF488A conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/2299R), CF488A conjugate, 0.1mg/mL is manufactured by Biotium.
Estimated delivery time for Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/2299R), CF488A conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/2299R), CF488A conjugate, 0.1mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.
This MAb is specific to ER alpha and shows minimal cross-reaction with other members of the family. ER is an important regulator of growth and differentiation in the mammary gland. Presence of ER in breast tumors indicates an increased likelihood of response to anti-estrogen (e.g. tamoxifen) therapy
Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.
Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.
A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.